Rebecca Paul

Max Jaderberg, Chief AI Officer at Isomorphic Labs with a background in teaching AI to play games, and Rebecca Paul, Head of Medicinal Drug Design with extensive experience in drug discovery, join the conversation. They delve into how AlphaFold 3 is transforming drug discovery by predicting molecular structures. The discussion covers tackling complex diseases, the challenges of drug efficacy, and the significance of AI in personalizing medicine. They even touch on the ambitious goal of designing treatments for previously deemed "undruggable" diseases.